Fig. 1From: Treatment with high-dose n-3 PUFAs has no effect on platelet function, coagulation, metabolic status or inflammation in patients with atherosclerosis and type 2 diabetesStudy flow chart. n-3 PUFAs omega-3 polyunsaturated fatty acids, EPA eicosapentaenoic acid, DHA docosahexaenoic acid, pts patients, OMT optimal medical therapyBack to article page